Fujian Wanchen Biotechnology Co. Ltd (300972) — Cash Flow Quality Index
Fujian Wanchen Biotechnology Co. Ltd (300972) has a Cash Flow Quality Index of 2.70x as of December 2025. Operating cash flow of CN¥3.63 Billion exceeds net income of CN¥1.34 Billion, indicating high earnings quality where cash backs reported profits. Explore Fujian Wanchen Biotechnology Co. Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Fujian Wanchen Biotechnology Co. Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Fujian Wanchen Biotechnology Co. Ltd across 6 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see 300972 operating cash flow.
Annual Cash Flow Quality Index for Fujian Wanchen Biotechnology Co. Ltd (2019–2025)
Year-by-year earnings quality comparison for Fujian Wanchen Biotechnology Co. Ltd.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.70x | CN¥3.63 Billion | CN¥1.34 Billion | ▼ -6.6% |
| 2024 | 2.89x | CN¥848.35 Million | CN¥293.52 Million | ▲ +96.1% |
| 2022 | 1.47x | CN¥70.38 Million | CN¥47.77 Million | ▼ -63.8% |
| 2021 | 4.07x | CN¥98.82 Million | CN¥24.28 Million | ▲ +150.4% |
| 2020 | 1.63x | CN¥156.24 Million | CN¥96.13 Million | ▼ -15.5% |
| 2019 | 1.92x | CN¥177.28 Million | CN¥92.19 Million | — |